Search

Your search keyword '"Frost, Adaani E."' showing total 97 results

Search Constraints

Start Over You searched for: Author "Frost, Adaani E." Remove constraint Author: "Frost, Adaani E."
97 results on '"Frost, Adaani E."'

Search Results

51. United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

58. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

59. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation

61. Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study

62. Severe ischemic injury to the proximal airway following lung transplantation: immediate and long-term effects on bronchial cartilage

63. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

66. Validation of two predictive models for survival in pulmonary arterial hypertension

67. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.

68. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

69. Validation Of The French Pulmonary Hypertension Network Equation To Estimate Survival: A REVEAL Analysis

73. Pulmonary Arterial Hypertension

77. A COMPARISON OF REVEAL REGISTRY DEMOGRAPHIC DATA WITH OTHER/PRIOR REGISTRIES OF PULMONARY ARTERIAL HYPERTENSION (PAH)

79. Ambrisentan Therapy for Pulmonary Arterial Hypertension

92. End points and clinical trial designs in pulmonary arterial hypertension Clinical and regulatory perspectives

93. Can Pulmonary Arterial Hypertensio Be Diagnosed by an Elevated Pulmonary Capillary Wedge Pressure Outside of the Guideline Criteria?

94. Dysregulation of BMPR2, Arginase IIand HMGA2Expression in Idiopathic Myelofibrosis and Secondary Myelofibrosis.

96. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

97. Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

Catalog

Books, media, physical & digital resources